# Randomized Trial of Two Antimalarial Treatments for Clearing Low Density P.Falciparum Parasitaemia in Sudan

> **NCT00330902** · PHASE3 · COMPLETED · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 104 (actual)

## Conditions studied

- Plasmodium Infections

## Interventions

- **DRUG:** sulfadoxine-pyrimethamine (SP) plus artesunate (AS)
- **DRUG:** primaquine (PQ) plus SP+AS

## Key facts

- **NCT ID:** NCT00330902
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** —
- **Final completion:** 2004-11
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2007-10-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00330902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00330902, "Randomized Trial of Two Antimalarial Treatments for Clearing Low Density P.Falciparum Parasitaemia in Sudan". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00330902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*